Full text not available from this repository.
The future of a pharmacological approach attenuating or preventing ischemia-reperfusion injury lies in a combination of drugs acting simultaneously on several steps of the injury cascades. Applying these substances during flush, before, and during implantation appears as an attractive strategy to protect extended criteria liver grafts.
|Item Type:||Journal Article, refereed, further contribution|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Clinic for Visceral and Transplantation Surgery|
|DDC:||610 Medicine & health|
|Deposited On:||14 Apr 2011 09:06|
|Last Modified:||28 Nov 2013 01:23|
|Publisher:||Lippincott Wiliams & Wilkins|
|Citations:||Web of Science®. Times Cited: 15|
Scopus®. Citation Count: 20
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page